Health Trials

International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases

ConditionNeutral Lipid Storage Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan

About this trial

This study aims to understand the state of onset of NLSD(neutral lipid storage disease) / TGCV(triglyceride deposit cardiovasculopathy) worldwide, background information of affected patients, and natural history of the disease, as well as exploring the prognostic factors and assessing the efficacy of disease-specific treatment.

Eligibility criteria

Qualifiers

Patients who are diagnosed with NLSD / TGCV

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

120 Participants
are grouped into 1 trial group

Sponsors and collaborators

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Lead sponsor

Source ClinicalTrials.gov